Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
Nowell M. Fine(University of Calgary), Shelley Zieroth(University of Manitoba), Christopher P. Venner(BC Cancer Agency), Jane Jayvena Narayan(University of British Columbia), Anique Ducharme(Montreal Heart Institute), Abhijat Kitchlu(University Health Network), Elizabeth Swiggum(University of British Columbia), Donna Reece(Princess Margaret Cancer Centre), Christopher Hahn(University of Pennsylvania), Margot K. Davis(University of British Columbia), Geneviève Giraldeau(Montreal Heart Institute), Rami Massie(Institute of Human Genetics), Kim Anderson, Marie-Claude Parent(Montreal Heart Institute), Mustafa Toma, Virginie Royal(Hôpital Maisonneuve-Rosemont), Sean Virani(University of British Columbia), Diego Delgado(Toronto General Hospital), Jonathan G. Howlett(University of Calgary), Lisa Mielniczuk(University of Ottawa), Natalie J. Galant(University of Toronto)
Cited by 112
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
|European Journal of Heart Failure|2021|1.5k